All the news Showing 10 of 37 articles from: Hepatocellular carcinoma (HCC)Get an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Co-infection with HCV increases cancer risk for people with HIV Michael Carter / 28 March 2017 People with HIV and hepatitis C virus (HCV) co-infection have an increased risk of non-AIDS-defining cancers compared to people with HIV mono-infection, investigators from Spain report in the online edition of AIDS. Even ... HCV infection increases risk of several non-liver-related cancers in elderly people Michael Carter / 09 March 2017 Hepatitis C virus (HCV) infection is associated with a range of non-liver-related cancers, investigators from the United States report in Cancer. The study population comprised over 1.6m elderly people with cancer and ... Are people with HIV and HCV co-infection who are cured of hepatitis C with DAAs at increased risk for liver cancer? Liz Highleyman / 27 February 2017 People with HIV and hepatitis C virus (HCV) co-infection who are successfully treated for hepatitis C using interferon-free direct-acting antiviral (DAA) therapy do not appear to have an increased likelihood of developing hepatocellular ... Nivolumab demonstrates good safety and promising response rates in liver cancer study Liz Highleyman / 03 January 2017 Nivolumab (Opdivo), an antibody that blocks the PD-1 receptor and restores T-cell anti-tumour activity, appeared safe and was associated with disease control and stabilisation in a phase 1/2 study of people with hepatocellular ... Liver cancer risk reduced after hepatitis C treatment, but vigilance needed for aggressive cancers in months after treatment Keith Alcorn / 14 November 2016 People who are cured of hepatitis C after a course of direct-acting antiviral (DAA) treatment do not have a higher risk of developing liver cancer (hepatocellular carcinoma), and probably have a reduced ... Diabetes is a risk factor for the development of liver cancer for people with cirrhosis successfully treated for HCV Michael Carter / 04 July 2016 Diabetes is a strong risk factor for hepatocellular carcinoma (HCC) in people with hepatitis C virus (HCV) infection who have received successful treatment for the infection, Swedish investigators report in Clinical Infectious Diseases. ... People treated for hepatitis C have unexpectedly high rate of liver cancer recurrence Liz Highleyman / 28 April 2016 Hepatitis C patients with cirrhosis who were treated with direct-acting antivirals had about twice the expected likelihood of developing hepatocellular carcinoma (HCC), with the excess risk seen in people with a previous history ... PD-1 checkpoint inhibitor nivolumab shows promise against liver cancer Liz Highleyman / 03 June 2015 Bristol-Myers Squibb's PD-1 immune checkpoint inhibitor nivolumab (Opdivo) demonstrated good safety and anti-tumour activity against hepatocellular carcinoma in a phase 1/2 study presented at the American Society of Clinical Oncology (ASCO) annual meeting this ... People with hepatitis C have higher cancer rates, even when excluding liver cancer Liz Highleyman / 11 May 2015 Hepatitis C patients in the Kaiser Permanente Southern California health maintenance organisation had significantly increased cancer rates compared to members without HCV infection, researchers reported at the European Association for the Study of ... Many hepatitis C patients with cirrhosis or advanced fibrosis face liver failure and liver cancer Liz Highleyman / 07 January 2015 Nearly one-third of chronic hepatitis C patients with liver cirrhosis and 12% with advanced fibrosis progressed to decompensation within five years, and 23% and 11%, respectively, died, according to a study presented ... ← Prev1234Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive